関与物質
| 役割 | 名称 | HCID | 仕込み量 |
|---|
| 反応物 | Colfosceril Palmitate | HCID 452110 | — |
| 反応物 | Salbutamol Sulfate | HCID 9884233 | — |
| 反応物 | Water ethanol | HCID 19096565 | — |
| 溶媒 | Ethanol | HCID 702 | — |
| 溶媒 | Water | HCID 962 | — |
| 溶媒 | L-Leucine | HCID 6106 | — |
| 生成物 | Salbutamol | HCID 2083 | — |
反応手順
The albuterol sulfate powder formulations listed in Table 7, were prepared as follows. Pre-spray drying solutions were prepared by dissolving the lipid in ethanol and albuterol sulfate and leucine in water. The ethanol solution was then mixed with the water solution at a ratio of 70/30 ethanol/water. Final total solute concentration of the solution used for spray drying varied from 1 g/L to 3 g/L. As an example, the DPPC/leucine/albuterol sulfate (76/16/8) spray drying solution was prepared by dissolving 760 mg of DPPC in 700 mL of ethanol, dissolving 160 mg leucine and 870 mg of albuterol sulfate in 300 mL water and then mixing the two solutions to yield one liter of cosolvent with a total solute concentration of 1 g/L (w/v). Higher solute concentrations of 3 g/L (w/v) were prepared by dissolving three times more of each solute in the same volumes of ethnaol and water. The solution was spray-dried as described above for the insulin containing formulation. Specifically, the inlet temperature was from about 110° C. to about 140° C., and the outlet temperature ranged from about 45-57° C.
情報源と証拠
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 特許番号 | US07628977B2 |
|---|
| 出典データセット | uspto-grants-2009_12 |
|---|
| ORD ID | ord-bf016e22225846a3a8f3a36c8e5887cd |
|---|
| 出典メモ | uspto-grants-2009_12 |
|---|